TCL Archive Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming March 22, 1985
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013